Your browser doesn't support javascript.
loading
Challenges Addressing Lung Cancer Screening for Patients With Multimorbidity in Primary Care: A Qualitative Study.
Kale, Minal S; Morgan, Orly; Wisnivesky, Juan; Schnur, Julie; Diefenbach, Michael A.
Afiliação
  • Kale MS; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York minal.kale@mountsinai.org.
  • Morgan O; Division of Medical Education, University of Miami Miller School of Medicine, Miami, Florida.
  • Wisnivesky J; Division of Medical Education, University of Miami Miller School of Medicine, Miami, Florida.
  • Schnur J; Department of Population Health Science and Policy, Center for Behavioral Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Diefenbach MA; Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York.
Ann Fam Med ; 22(2): 103-112, 2024.
Article em En | MEDLINE | ID: mdl-38527820
ABSTRACT

PURPOSE:

Many individuals who are eligible for lung cancer screening have comorbid conditions complicating their shared decision-making conversations with physicians. The goal of our study was to better understand how primary care physicians (PCPs) factor comorbidities into their evaluation of the risks and benefits of lung cancer screening and into their shared decision-making conversations with patients.

METHODS:

We conducted semistructured interviews by videoconference with 15 PCPs to assess the extent of shared decision-making practices and explore their understanding of the intersection of comorbidities and lung cancer screening, and how that understanding informed their clinical approach to this population.

RESULTS:

We identified 3 themes. The first theme was whether to discuss or not to discuss lung cancer screening. PCPs described taking additional steps for individuals with complex comorbidities to decide whether to initiate this discussion and used subjective clinical judgment to decide whether the conversation would be productive and beneficial. PCPs made mental assessments that factored in the patient's health, life expectancy, quality of life, and access to support systems. The second theme was that shared decision making is not a simple discussion. When PCPs did initiate discussions about lung cancer screening, although some believed they could provide objective information, others struggled with personal biases. The third theme was that ultimately, the decision to be screened was up to the patient. Patients had the final say, even if their decision was discordant with the PCP's advice.

CONCLUSIONS:

Shared decision-making conversations about lung cancer screening differed substantially from the standard for patients with complex comorbidities. Future research should include efforts to characterize the risks and benefits of LCS in patients with comorbidities to inform guidelines and clinical application.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article